首页 › 膀胱癌 › 密苏里州 › Lee's Summit
Lee's Summit MO 膀胱癌临床试验
3项针对 膀胱癌的研究正在 Lee's Summit及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
招募中2 期
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
招募中3 期
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit
其他城市的 膀胱癌试验
- New York City, NY34 项研究
- Nashville, TN31 项研究
- Houston, TX31 项研究
- Dallas, TX27 项研究
- Washington, DC26 项研究
- Boston, MA26 项研究
- Los Angeles, CA24 项研究
- Baltimore, MD24 项研究
- St. Louis, MO22 项研究
- Edison, NJ22 项研究
- Philadelphia, PA21 项研究
- Chicago, IL21 项研究
Lee's Summit的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。